Prelude Capital Management, LLC Novavax Inc Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 8,100 shares of NVAX stock, worth $105,057. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,100Holding current value
$105,057% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
242Shares Held
76.1MCall Options Held
5.06MPut Options Held
7.19M-
State Street Corp Boston, MA16.9MShares$219 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$175 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.43MShares$122 Million0.0% of portfolio
-
Shah Capital Management8.12MShares$105 Million19.75% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$33.6 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $1.01B
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...